APOE genotypes and dyslipidemias in a sample of the Portuguese population

The objective of this work was to study the distribution of apolipoprotein E (APOE) genotypes in a sample of the Portuguese population, and its association with the dyslipidemias observed. Study participants were healthy users of local Public Health Laboratories in six regions of mainland Portugal (Porto, Vila Real, Viseu, Lisboa, Portalegre and Faro). A total of 779 men and 1153 women aged 15-74 years agreed to participate. Fasting lipid levels and APOE genotypes were determined centrally at the National Institute of Health in Lisboa. The frequency distribution of APOE alleles was: epsilon2=5.3%, epsilon3=84.9% and epsilon4=9.8%. Dyslipidemias were present in 66.6% of men and 60.7% of women. Comparison of APOE genotypes and relative allele frequencies showed that in dyslipidemic compared to normolipidemic subjects, the epsilon4 allele was more frequent in both sexes, although in a more pronounced way in men than in women due to higher frequencies of epsilon3/epsilon4 and epsilon4/epsilon4 genotypes. The known association of the epsilon4 allele with high cholesterol levels, the association of the epsilon2 allele with low cholesterol levels, and the association of the epsilon2 allele with high levels of triglycerides and low levels of high-density lipoprotein-cholesterol were confirmed in this study

POSTNATALLY HYDRONEPHROSIS (HN) IN CHILDREN WITH ANTENATALLY DIAGNOSED HYDRONEPHROSIS: SURGERY OR MEDICAL TREATMENT?

Objectives: There is no formal agreement or criteria utilized to establish a standard of treatment in children with antenatally diagnosed HN. Methods: We analyzed our own experience in addition to the protocols attending to this subject. Twenty eight (28) children with unilateral HN were assessed from October 1999 through October 2005 and the anteroposterior diameter of renal pelvis (APDP) was measured. Results: Patients underwent surveillance with US and cintilography in 3, 6, 12 and 24 months. The treatment results were reviewed following the classification of Society of Fetal Urology: slight (2 to 5 mm), moderate (6 to 10 mm) and severe (>10-15 mm). Conclusions: We concluded that slight HN would never be operated on while the severe ones would always be. The moderate HN, on the other hand, would remain under surveillance with US and cintilography for two years.32101031103

Triple therapy in refractory detrusor overactivity: a preliminary study

To evaluate in a prospective study the impact of the 'three-drug therapy' (antimuscarinic, alpha-blocker and tricyclic antidepressants) on the treatment of refractory detrusor overactivity (DO). Data from 27 consented patients with refractory DO were available for study. They were asked to complete a daily urinary chart and underwent urodynamic evaluation (UD) before and 60 days after treatment. Response to treatment was considered the presence of one or less involuntary detrusor contractions (IDC) on post-treatment UD. Statistical analysis was performed with Fisher and Mann-Whitney tests, besides Spearman's correlation. P values < 0.05 were considered significant. The mean follow-up was 15 months. The comparison of the daily urinary chart before and after treatment showed significant increase on bladder capacity and decreases on urgency, urge-incontinence and frequency. Objective data from UD showed that the mean maximum bladder capacity (MBC) ranged from 200 to 300 mL (P < 0.001) with treatment. The same trend was observed with the other UD variables. When compared to baseline, the questionnaire OAB-v8 showed significant improvement (P < 0.01). Main side effects comprised dry mouth and constipation (40%), with average scores of 5.16 and 3.08, respectively (visual scale from 0 to 10). Triple therapy may be an effective, easily employed and well-tolerated option to refractory DO treatment. More studies are necessary to achieve more consistent data on the matter.281798

[postnatally Hydronephrosis (hn) In Children With Antenatally Diagnosed Hydronephrosis: Surgery Or Medical Treatment?].

There is no formal agreement or criteria utilized to establish a standard of treatment in children with antenatally diagnosed HN. We analyzed our own experience in addition to the protocols attending to this subject. Twenty eight (28) children with unilateral HN were assessed from October 1999 through October 2005 and the anteroposterior diameter of renal pelvis (APDP) was measured. Patients underwent surveillance with US and cintilography in 3, 6, 12 and 24 months. The treatment results were reviewed following the classification of Society of Fetal Urology: slight (2 to 5 mm), moderate (6 to 10 mm) and severe (> 10-15 mm). We concluded that slight HN would never be operated on while the severe ones would always be. The moderate HN, on the other hand, would remain under surveillance with US and cintilography for two years.321031-